About Intravascular Lithotripsy
Lithoplasty is the term that was used for the application of lithotripsy in angioplasty but now it is known as intravascular lithotripsy (IVL). Intravascular lithotripsy is an innovative technology design that addresses the heavily calcified lesions by cracking the shock waves. The technology delivers unfocused, circumferential, pulsatile mechanical energy to safely disrupt the calcium. The market of the following technology is expected to grow in the coming years. The awareness about the technology is increasing and the demand by the patients is also increasing at the same time. The COVID-19 pandemic has shown a serious impact on this market. The prices of raw materials have changed which in turn is affecting the entire treatment cost. The flow of patients in the hospitals has decreased because of which the operations have decreased. It is a procedure to break the stones present in the kidney, bladder, and Uterus.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Intravascular Lithotripsy market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Siemens AG (Germany), Olympus America (United States), Boston Scientific (United States), Medispec LTD (India), Elmed Electronics & Medical Industry & Trade Inc (Turkey), Shockwave Medical Inc (United States) and Dornier MedTech GmbH (Germany) are some of the key players that are part of study coverage.
Segmentation Overview
AMA Research has segmented the market of Global Intravascular Lithotripsy market by Type (Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal (Endoscopic Lithotripsy) and Percutaneous Lithotripsy), Application (Kidney Disorders, Coronary Artery Disease, Peripheral Arterial Disease, Facilitated Vascular Access and Others) and Region.
On the basis of geography, the market of Intravascular Lithotripsy has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End-Users, the sub-segment i.e. Hospitals will boost the Intravascular Lithotripsy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Adoption of the Technique Due to Low-cost and Minimal Recovery Time
Market Growth Drivers:
Rising Prevalence of Complications Associated with Kidney Stones and The Increasing Adoption of Intravascular Lithotripsy Technique
Challenges:
Risk Associated with Vessel Trauma
Restraints:
Stringent Regulations by Government Authorities
Opportunities:
Growing Improvements and Developments Across the Healthcare Industry
Market Leaders and their expansionary development strategies
In March 2023, Shockwave Medical, Inc., a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced the full U.S. commercial availability of the Shockwave L6 Peripheral IVL Catheter following clearance by the U.S. Food and Drug Administration (FDA). The Shockwave L6 catheter is purpose-built to modify calcification in otherwise difficult-to-treat lesions in large peripheral vessels, including the iliac and the common femoral arteries. Calcification in these arteries is common and associated with decreased procedural success and increased complications with standard endovascular techniques.1
In October 22023, Shockwave Medical introduced of its Shockwave C2+ coronary intravascular lithotripsy (IVL) catheter in the United States.The company says the C2+ catheter provides 50% more pulses per catheter than the C2 iteration
Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Providers of Intravascular Lithotripsy, Venture Capitalists and Private Equity Firms and End-Use Industry
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.